News and Media

Latest News Release
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health Completes Acquisition of Denver Biomedical, a Manufacturer of Specialized Medical Devices
05/23/2006

McGaw Park, Ill., May 23, 2006 -- Cardinal Health, Inc. (NYSE: CAH), the leading provider of products and services supporting the health-care industry, today announced it has completed the acquisition of Denver Biomedical, Inc., a designer and manufacturer of specialized medical products for chronic fluid management in the chest and abdomen. Terms of the agreement were not disclosed. 

 

Based in Golden, Colorado, Denver Biomedical has 50 employees. It markets specialty drainage products worldwide for hospital and home use, primarily for terminally-ill cancer patients. Founded in 1969, Denver Biomedical’s products include the Pleurx® Pleural Catheter System, the Denver® Ascites Shunt, and the Denver® Pleural Effusion Shunt. Denver Biomedical was the first company to receive FDA clearance specifically for an indwelling catheter for drainage of chronic pleural and ascitic fluids.

 

”Well recognized by clinicians, Denver Biomedical’s products are a great fit with our existing business,” said Tom Daulton, vice president and general manager, Special Procedures, Cardinal Health. “These products significantly enhance patient quality of life and reduce hospital costs.”

 

Cardinal Health manufactures and markets a full range of industry-leading devices used in biopsy and spine procedures. It’s major product lines in these areas include the Vertemax Vertebral Augmentation System, Achieve®, Temno® and Tru-Cut® biopsy needles and trays and Jamshidi® lbone marrow biopsy needles.

 

“We take great pride in our products, support to the medical community and our passion for service excellence. After careful consideration, we selected Cardinal Health as a partner that could successfully continue this tradition,” said Bonnie Vivian, president, Denver Biomedical. “We are looking forward to accelerating our growth as part of Cardinal Health.”

 

The chronic fluid drainage market provides a vital service to patients, providing at-home relief for fluid build-up. This acquisition supports Cardinal Health’s strategic focus and rounds out the company’s growing Para/Thoracentesis product offering.

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $75 billion, global company serving the health-care industry with a broad portfolio of products and services. Through its diverse offering, Cardinal Health delivers integrated health-care solutions that help customers reduce their costs, improve efficiency and deliver better care to patients. The company manufactures, packages and distributes pharmaceuticals and medical supplies, offers a range of clinical services and develops automation products that improve the management and delivery of supplies and medication for hospitals, physician offices and pharmacies. Ranked No. 19 on the Fortune 500, Cardinal Health employs more than 55,000 people on six continents. More information about the company may be found at www.cardinalhealth.com.

More Company News
02/06/2024

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on...

02/06/2024

Cardinal Health (NYSE: CAH) today released its Fiscal 2023 Environmental, Social and Governance (ESG) Report, highlighting the company's work toward building a healthier, more equitable future....

02/01/2024

Revenue increased 12% to $57.4 billion GAAP1 operating earnings were $482 million; GAAP diluted EPS was $1.43 Non-GAAP operating earnings increased 20% to $562 million; non-GAAP diluted EPS...

01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

View all company news »